138 related articles for article (PubMed ID: 26087058)
1. Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids.
Laugsand EA; Skorpen F; Kaasa S; Sabatowski R; Strasser F; Fayers P; Klepstad P
Clin Transl Gastroenterol; 2015 Jun; 6(6):e90. PubMed ID: 26087058
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.
Laugsand EA; Fladvad T; Skorpen F; Maltoni M; Kaasa S; Fayers P; Klepstad P
Eur J Cancer; 2011 Jul; 47(11):1682-91. PubMed ID: 21570824
[TBL] [Abstract][Full Text] [Related]
3. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
[TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine.
Solismaa A; Kampman O; Lyytikäinen LP; Seppälä N; Viikki M; Mononen N; Lehtimäki T; Leinonen E
J Clin Psychopharmacol; 2018 Jun; 38(3):193-199. PubMed ID: 29620694
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
Kurita GP; Ekholm O; Kaasa S; Klepstad P; Skorpen F; Sjøgren P
Brain Behav; 2016 Jul; 6(7):e00471. PubMed ID: 27247849
[TBL] [Abstract][Full Text] [Related]
6. Genetic Factors Associated With Pain Severity, Daily Opioid Dose Requirement, and Pain Response Among Advanced Cancer Patients Receiving Supportive Care.
Yennurajalingam S; Astolfi A; Indio V; Beccaro M; Schipani A; Yu R; Shete S; Reyes-Gibby C; Lu Z; Williams JL; Yeun SC; Anderson AE; Biasco G; Bruera E
J Pain Symptom Manage; 2021 Oct; 62(4):785-795. PubMed ID: 33848569
[TBL] [Abstract][Full Text] [Related]
7. Inpatient use of laxatives during opioid administration in children with sickle cell disease.
O'Brien SH; Fan L; Kelleher KJ
Pediatr Blood Cancer; 2010 Apr; 54(4):559-62. PubMed ID: 20049931
[TBL] [Abstract][Full Text] [Related]
8. Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.
Barratt DT; Klepstad P; Dale O; Kaasa S; Somogyi AA
PLoS One; 2015; 10(9):e0137179. PubMed ID: 26332828
[TBL] [Abstract][Full Text] [Related]
9. Management of opioid-induced constipation.
Prichard D; Norton C; Bharucha AE
Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
[TBL] [Abstract][Full Text] [Related]
10. Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study.
Mancini IL; Hanson J; Neumann CM; Bruera ED
J Palliat Med; 2000; 3(1):49-56. PubMed ID: 15859721
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis for opioid-induced constipation in elderly long-term care residents: a cross-sectional study of Medicare beneficiaries.
Max EK; Hernandez JJ; Sturpe DA; Zuckerman IH
Am J Geriatr Pharmacother; 2007 Jun; 5(2):129-36. PubMed ID: 17719515
[TBL] [Abstract][Full Text] [Related]
12. The use of opioids and laxatives, and incidence of constipation, in patients requiring neck-of-femur (NOF) surgery: a pilot study.
Davies EC; Green CF; Mottram DR; Pirmohamed M
J Clin Pharm Ther; 2008 Oct; 33(5):561-6. PubMed ID: 18834372
[TBL] [Abstract][Full Text] [Related]
13. The genetic influences on oxycodone response characteristics in human experimental pain.
Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
[TBL] [Abstract][Full Text] [Related]
14. The relationship between opioid use and laxative use in terminally ill cancer patients.
Sykes NP
Palliat Med; 1998 Sep; 12(5):375-82. PubMed ID: 9924600
[TBL] [Abstract][Full Text] [Related]
15. [Laxative policy for terminal patients ineffective].
Schoorl J; Zylicz Z
Ned Tijdschr Geneeskd; 1997 Apr; 141(17):823-6. PubMed ID: 9221363
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics of Cancer Pain Treatment Outcomes in Asian Populations: A Review.
Satkunananthan SE; Suppiah V; Toh GT; Yow HY
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36422103
[TBL] [Abstract][Full Text] [Related]
17. The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use.
LoCasale RJ; Datto CJ; Margolis MK; Tack J; Coyne KS
Int J Clin Pract; 2015 Dec; 69(12):1448-56. PubMed ID: 26344578
[TBL] [Abstract][Full Text] [Related]
18. The impact of opioids, anticholinergic medications and disease progression on the prescription of laxatives in hospitalized palliative care patients: a retrospective analysis.
Clark K; Lam LT; Agar M; Chye R; Currow DC
Palliat Med; 2010 Jun; 24(4):410-8. PubMed ID: 20348271
[TBL] [Abstract][Full Text] [Related]
19. Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose.
Wirz S; Nadstawek J; Elsen C; Junker U; Wartenberg HC
Eur J Cancer Care (Engl); 2012 Jan; 21(1):131-40. PubMed ID: 21880080
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of constipation in the palliative care phase].
de Groot JW; Peters FT; Reyners AK
Ned Tijdschr Geneeskd; 2010; 154():A2224. PubMed ID: 21176258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
